Tumor dose heterogeneity informed biological optimization of combination Lu-177 PSMA radiopharmaceutical therapy and Ir-192 high dose rate prostate brachytherapy
Date:
JB Schulz, O Kwon, C Haasch, AE Besemer, JM Floberg, MJ Lawless, JM Slagowski, B Bednarz
Oral and poster. Best in Physics (Therapy).